Cylicocyclus

Cylicocyclus is a genus of small roundworms belonging to the family Strongylidae. These are widely distributed parasitic nematodes that, in veterinary practice, are collectively known as cyathostomins or small strongyles.

Morphologically, adult worms are small, thread-like nematodes, typically white or greyish. They possess a well-developed buccal capsule at the anterior end, which facilitates attachment to the host's intestinal mucosa.

Unlike large strongyles, cyathostomins are smaller in size, but their population within a host can reach thousands of individuals. Precise species identification usually requires microscopic examination of the buccal capsule and genital structures.

These parasites are obligate, meaning they must reside within a warm-blooded host to complete their life cycle. Outside the host, they survive in the larval stage provided there is sufficient environmental moisture.

Cylicocyclus exhibits high environmental plasticity, making it prevalent in nearly all regions where equine farming is practiced.

The primary hosts for Cylicocyclus are horses, ponies, mules, and donkeys. Adult worms parasitize the large intestine, particularly the cecum and colon.

The parasite causes mechanical damage to the intestinal mucosa by attaching to it and feeding on host tissues and luminal contents. This triggers inflammatory responses of varying severity.

Massive infestations lead to cyathostominosis. In weakened animals, especially young stock, the pathology is acute and may result in severe weight loss or cachexia.

Chronic infestation results in malabsorption of nutrients, which negatively impacts the growth, productivity, and overall health status of the equine population.

In severe cases, intestinal motility is disrupted, leading to congestion and an increased risk of secondary gastrointestinal disorders and colic.

The parasite's biological cycle is closely tied to seasonal variations in temperature and humidity. Larvae in the environment are most active during the warmer months.

Infection primarily occurs on pastures, as equines ingest infective larvae while grazing. The peak infection risk typically coincides with the middle to late grazing season.

During winter, larvae may enter a state of hypobiosis—a developmental delay within the intestinal mucosa of the host, which is a vital survival strategy for the species.

In the spring, mass emergence of larvae from the mucosa into the intestinal lumen occurs, often aligning with the start of the grazing season and increased grass growth.

Understanding these seasonal dynamics is critical for scheduling strategic deworming programs, as the risk of clinical symptoms is highest during periods of increased parasite activity.

Clinical signs of infestation are often non-specific. The first indication is usually a reduction in body condition scores despite an adequate appetite.

Animals may suffer from chronic diarrhea that alternates with constipation. The hair coat often loses its sheen, becoming dry and coarse, accompanied by general lethargy.

Blood tests frequently reveal anemia and hypoproteinemia due to nutrient depletion and blood loss caused by the feeding habits of the worms.

Young horses may exhibit stunted growth and developmental delays, along with a predisposition to recurring episodes of colic with unclear etiology.

During the mass emergence of larvae into the intestinal lumen, acute inflammation may manifest as elevated body temperature and severe abdominal pain.

The cornerstone of control is strategic deworming using broad-spectrum anthelmintics to which cyathostomins are susceptible.

It is essential to rotate anthelmintic drug classes to prevent the development of drug resistance within the parasite population.

Recommended management practices include regular pasture rotation, mechanical harrowing of fields to destroy larvae, and proper manure composting.

Maintaining high standards of stable hygiene, including regular cleaning and disinfection of stalls, significantly reduces the infectious pressure on the animals.

Ongoing laboratory monitoring, including fecal egg count tests, is necessary to assess the efficacy of treatments and identify carrier animals early.